Turning Point Therapeutics/ US90041T1088 /
| 5/23/2022 7:39:24 PM | Chg. +0.12 | Volume | Bid7:39:43 PM | Ask7:39:43 PM | High | Low |
|---|---|---|---|---|---|---|
| 36.94USD | +0.31% | 18,706 Turnover: 687,760.93 |
33.64Bid Size: 100 | 39.99Ask Size: 101 | 37.67 | 36.32 |
GlobeNewswire
3/29
Turning Point Therapeutics Announces Appointment of Brian Sun, M.S., J.D., as Incoming General Couns...
GlobeNewswire
3/21
Turning Point Therapeutics Announces Achievement of Enrollment Goal for TRIDENT-1 NTRK-Positive TKI-...
GlobeNewswire
3/11
Colfax Announces Board of Directors for Enovis, the Post-Spinoff Medical Technology Company
GlobeNewswire
3/7
Turning Point Therapeutics to Participate in 42nd Annual Cowen Healthcare Conference - Update
GlobeNewswire
3/1
Turning Point Therapeutics to Participate in 42nd Annual Cowen Healthcare Conference
GlobeNewswire
3/1
Zai Lab Announces Financial Results and Corporate Updates for Twelve Months Ended December 31, 2021
GlobeNewswire
2/28
Olema Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Up...
GlobeNewswire
2/28
Turning Point Therapeutics Reports Fourth-Quarter and Full Year 2021 Financial Results, Provides Ope...
GlobeNewswire
2/17
Zai Lab Announces Breakthrough Therapy Designation Granted for Repotrectinib in China
GlobeNewswire
1/20
Turning Point Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for...
GlobeNewswire
1/18
Turning Point Therapeutics Provides Updates and Anticipated 2022 Clinical and Discovery Pipeline Mil...
GlobeNewswire
11/29/2021
Bright Peak Therapeutics Appoints Jacob Chacko, M.D., as Chair of its Board of Directors
GlobeNewswire
11/10/2021
View, Inc. Provides Update on Audit Committee Independent Investigation and 2021 Revenue Guidance
GlobeNewswire
11/9/2021
Turning Point Therapeutics Reports Third-Quarter Financial Results, Provides Operational Updates
GlobeNewswire
11/8/2021
Turning Point Therapeutics Announces Appointment of Adam Levy as Senior Vice President of Investor R...
GlobeNewswire
10/23/2021
Turning Point Therapeutics Presents Early Clinical Data for Repotrectinib From Care Study in Pediatr...
GlobeNewswire
10/13/2021
Turning Point Therapeutics and EQRx Announce Clinical Collaboration to Evaluate Elzovantinib in Comb...